Table 3.

Frequency of cerebrospinal fluid (CSF) and serum samples with detectable levels of anti-Epstein Barr nuclear antigen 1 (EBNA-1) and anti-viral capsid antigen (VCA) IgG in patients with relapsing-remitting multiple sclerosis (RRMS), other inflammatory neurological disorders (OIND) and noninflammatory neurological disorders (NIND)

	Anti-EBNA-1 IgG		Anti-VCA IgG
	CSF	Serum	CSF	Serum
RRMS (n = 100)	96/100 (96%)a	99/100 (99%)	65/100 (65%)	90/100 (90%)
OIND (n = 100)	91/100 (91%)	96/100 (96%)	86/100 (86%)b	94/100 (94%)
NIND (n = 100)	86/100 (86%)	94/100 (94%)	74/100 (74%)	90/100 (90%)

CSF anti-EBNA-1 IgG (Chi-square with Bonferroni correction): ^aRRMS versus NIND (P <0.05); CSF anti-VCA IgG (Chi-square with Bonferroni correction): ^bOIND versus RRMS (P <0.001).